Kneu Health secures $2M from Cedars-Sinai and Oxford Science Enterprises for neurology care
Summary
Kneu Health, a neurology health-tech spin-out from the University of Oxford, has secured $2 million in co-investment from Cedars-Sinai and Oxford Science Enterprises. The funding marks the launch of a groundbreaking partnership to co-build and co-invest in health-tech startups. The investment will support Kneu Health's expansion into the US, starting with a six-month pilot program at Cedars-Sinai.
Why it matters
Kneu Health's platform, backed by over a decade of Oxford research, empowers clinicians, caregivers, and patients with improved symptom monitoring, tailored care plans, and proactive clinical interventions for Parkinson's disease and dementia. The Cedars-Sinai partnership will bring the platform to 150 patients, paving the way for broader US adoption and transforming neurology care globally.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial